Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Lung Perfusion (IVLP) as an Adjuvant Treatment for Patients Undergoing Surgical Resection of Pulmonary Metastases of Bone and Soft Tissues Sarcomas

NCT02811523 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02811523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02811523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Lung Perfusion (IVLP) as an Adjuvant Treatment for Patients Undergoing Surgical Resection of Pulmonary Metastases of Bone and Soft Tissues Sarcomas
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Recruiting
Start date
February 29, 2016
Completion date
September 30, 2030
Enrollment
17 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone sarcoma, pulmonary metastases, soft tissue sarcoma